ONCOLOGIC OUTCOMES OF INTRAVESICAL THERAPY IN THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY

被引:0
|
作者
Zaeem, Lone
Andrew, Wood
Rebecca, Campbell
Georges-Pascal, Haber
Mohamed, Eltemamy
Samuel, Haywood C.
Christopher, Weight J.
Nima, Almassi
Reza, Alaghehbandan
Li Jianbo
Byron, Lee H.
机构
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA
[4] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[5] MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
关键词
D O I
10.1016/j.urolonc.2024.01.202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
165
引用
收藏
页码:S71 / S71
页数:1
相关论文
共 50 条
  • [31] Intravesical Therapies in Non-muscle Invasive Bladder Tumors
    Geyik, Serdar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2019, 18 (01): : 24 - 29
  • [32] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Velaer, Kyla N.
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    CURRENT UROLOGY REPORTS, 2016, 17 (05)
  • [33] PRELIMINARY DATA ON PSA CHANGES DURING INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Gesolfo, Cristina Scalici
    Alonge, Vincenza
    Chiapparrone, Gaetano
    Solazzo, Antonio
    Napoli, Enrica
    Sommatino, Francesco
    Vella, Marco
    Serretta, Vincenzo
    ANTICANCER RESEARCH, 2013, 33 (05) : 2269 - 2270
  • [34] ADJUVANT CANCER PEPTIDE VACCINE TREATMENT WITH INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Obara, Wataru
    Hara, Isao
    Miki, Tsuneharu
    Mimata, Hiromitsu
    Shuin, Taro
    Fujioka, Tomoaki
    JOURNAL OF UROLOGY, 2014, 191 (04): : E570 - E570
  • [35] The optimal management of variant histology in muscle invasive bladder cancer
    Tiwari, Raj Vikesh
    Ngo, Nye Thane
    Lee, Lui Shiong
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2965 - 2975
  • [36] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Kyla N. Velaer
    Ryan L. Steinberg
    Lewis J. Thomas
    Michael A. O’Donnell
    Kenneth G. Nepple
    Current Urology Reports, 2016, 17
  • [37] ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Drupad, Annapureddy
    Jacob, Taylor
    Jeffrey, Howard
    Solomon, Woldu L.
    Yair, Lotan
    Shen, Tan Wei
    Ashish, Kamat
    Ian M, McElree
    Vignesh, Packiam T.
    Michael, O'Donnell
    Davaro, Facundo
    Roger, Li
    Kendrick, Yim
    Mark, Preston A.
    Stephen, Harrington
    Elizabeth, Dyer
    Jay, Raman
    Anna, Black
    Peter, Black
    Pratik, Kanabur
    Seth, Lerner
    Mathieu, Roumiguie
    Gary, Steinberg
    William, Huang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S52 - S53
  • [38] PATIENT-REPORTED TOXICITY DURING INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Clements, Matthew B.
    Liso, Nicole
    Seiden, Benjamin
    Donahue, Timothy
    Goh, Alvin
    Bochner, Bernard H.
    Pietzak, Eugene
    JOURNAL OF UROLOGY, 2024, 211 (05): : E993 - E993
  • [39] Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
    Flammia, Rocco Simone
    Chierigo, Francesco
    Wuernschimmel, Christoph
    Wenzel, Mike
    Horlemann, Benedikt
    Tian, Zhen
    Borghesi, Marco
    Leonardo, Costantino
    Tilki, Derya
    Shariat, Shahrokh F.
    Anceschi, Umberto
    Chun, Felix K. H.
    Terrone, Carlo
    Saad, Fred
    Gallucci, Michele
    Karakiewicz, Pierre I.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (03) : 240 - 247
  • [40] Update on the management of non-muscle invasive bladder cancer
    Aldousari, Saad
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (01): : 56 - 64